Sign in
4

Changes in Ownership

CERENOME, INC. Filed Acc 0001209191-17-019941

Options or other derivatives

  • VP and GM Cell Therapy acquired 42,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HARRIS JOHN DAVID · VP and GM Cell Therapy

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-03-08 Grant or award : show line 1 in the form Incentive Stock Option (right to buy) +42,000 42,000 D
Loading xslF345X03/doc4.xml…